Acticor Biotech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • IPO Registration

  • Employees
  • 23

Employees

  • Latest Deal Type
  • IPO

  • Latest Deal Amount
  • $18M

  • Investors
  • 14

Acticor Biotech General Information

Description

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Contact Information

Website
www.acticor-biotech.com
Ownership Status
In IPO Registration
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Hôpital Bichat-Inserm U1148
  • 46, rue Henri Huchard, Cedex 18
  • 75018 Paris
  • France
+33 09 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acticor Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. IPO 01-Nov-2021 $18M 000.00 000.00 Completed Clinical Trials - Phase 3
6. Later Stage VC 07-Sep-2021 00.000 000.00 000.00 Completed Clinical Trials - Phase 3
5. Later Stage VC (Series B) 06-Nov-2019 000.00 000.00 000.00 Completed Clinical Trials - Phase 2
4. Early Stage VC 20-Dec-2017 00.000 00.000 000.00 Completed Pre-Clinical Trials
3. Early Stage VC 07-Feb-2017 00.000 00.000 00.000 Completed Pre-Clinical Trials
2. Seed Round 26-Jan-2015 $782K $782K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Acticor Biotech’s complete valuation and funding history, request access »

Acticor Biotech Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preference 000,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Preference 00,000 00.000000 000.00 000.00 00 000.00 0.000
Preference 28,039 $1.177398 $64.76 $64.76 1x $64.76 6.7%
Ordinary 17,552 $1.177398 $44.74 $44.74 1x $44.74 4.2%
To view Acticor Biotech’s complete cap table history, request access »

Acticor Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emerge
Biotechnology
Paris, France
23 As of 2023
000.00
00.00 0000-00-00
00000000 000.00

000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000000000000
Gaithersburg, MD
00 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
0000 000000000
Kulmbach, Germany
00 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acticor Biotech Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 Private Equity-Backed Kulmbach, Germany 00 000000000000
0000000 0000000000 Formerly VC-backed Cambridge, MA 0000 00.000 0000 00.000
00000 Formerly VC-backed Cambridge, MA 000 00000 000000&0
0000000 0000000000 Formerly VC-backed San Diego, CA 00 00000 000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Acticor Biotech Executive Team (11)

Name Title Board Seat Contact Info
Sophie Lebel-Binay Ph.D General Manager, Scientific Director, Chief Scientific & Operating Officer
Patricia Zilliox Independent Director
Philippe Billiald Ph.D Scientific Founder & Scientific Consultant
Gilles Avenard MD Co-Founder & Chief Executive Officer, Board Member
Martine Jandrot-Perrus Scientific Founder
You’re viewing 5 of 11 executive team members. Get the full list »

Acticor Biotech Board Members (13)

Name Representing Role Since
Alain Munoz Ph.D Self Chairman and Independent Member 000 0000
Alain Parthoens Newton BioCapital Board Observer 000 0000
Catherine Boule Karista (Paris) Board Member 000 0000
Corinne Le Goff Self Board Member 000 0000
Gilles Avenard MD Acticor Biotech Co-Founder & Chief Executive Officer, Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Acticor Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acticor Biotech Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
A&B (HK) Company Venture Capital Minority 000 0000 000000 0
ANAXAGO Real Estate Minority 000 0000 000000 0
Antoine Lindrec Angel (individual) Minority 000 0000 000000 0
China Medical System Corporation Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Acticor Biotech Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AVCare 06-Nov-2019 0000000000 Diagnostic Equipment 000000 00
To view Acticor Biotech’s complete acquisitions history, request access »

Ready to get started?

Request a free trial